Subscribe to access full data
Company Economic Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Basic Materials Mid (2.2bn) 0 No activity — 15–50%
Consumer Non-Cyclicals Mid (2.2bn) 0 No activity — 0–15%
GB Genus PLC (GNS)
Healthcare Mid (2.2bn) 1–5 < $100K 0–15% 0–15%
Consumer Cyclicals Mid (2.2bn) 1–5 -< $100K -0–15% 0–15%
Financials Mid (2.2bn) 0 No activity — 50%+
Financials Mid (2.2bn) 0 No activity — 0–15%
Industrials Mid (2.2bn) 1–5 < $100K 0–15% 15–50%
Real Estate Mid (2.2bn) 1–5 < $100K 0–15% 0–15%
Financials Mid (2.2bn) 1–5 $100K–$1M 0–15% 0–15%
Financials Mid (2.2bn) 0 No activity — 50%+
US HNI Corp (HNI)
Industrials Mid (2.2bn) 0 No activity — 0–15%
US Vericel Corp (VCEL)
Healthcare Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
IN Natco Pharma Ltd (NATCOPHARM)
Healthcare Mid (2.2bn) 0 No activity — 50%+
Technology Mid (2.2bn) 0 No activity — 0–15%
SE Granges AB (GRNG)
Basic Materials Mid (2.2bn) 0 No activity — 0–15%
Consumer Non-Cyclicals Mid (2.2bn) 0 No activity — 50%+
Energy Mid (2.2bn) 0 No activity — 0–15%
Healthcare Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
US AvePoint Inc (AVPT)
Technology Mid (2.2bn) 0 No activity — 15–50%
Industrials Mid (2.2bn) 0 -$1M–$10M -0–15% 15–50%
Financials Mid (2.2bn) -1–5 -$1M–$10M -0–15% 15–50%
Financials Mid (2.2bn) 0 No activity — 0–15%
NL TKH Group NV (TWEKA)
Industrials Mid (2.2bn) 0 No activity — 0–15%
IN Affle 3i Ltd (AFFLE)
Consumer Cyclicals Mid (2.2bn) 1–5 < $100K 0–15% 50%+
Financials Mid (2.2bn) 0 No activity — 0–15%
Financials Mid (2.2bn) 0 No activity — 50%+
Consumer Cyclicals Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Energy Mid (2.2bn) -1–5 -$100M+ -15–50% 15–50%
Energy Mid (2.2bn) -1–5 -$1M–$10M -0–15% 15–50%
Industrials Mid (2.2bn) 0 No activity — 50%+
Industrials Mid (2.2bn) 0 No activity — 0–15%
Industrials Mid (2.2bn) 0 No activity — —
Technology Mid (2.2bn) -1–5 -$1M–$10M -0–15% 50%+
- Mid (2.1bn) 0 No activity — 0–15%
US ePlus inc (PLUS)
Technology Mid (2.1bn) 0 No activity — 0–15%
Energy Mid (2.1bn) 1–5 $100K–$1M 0–15% 0–15%
- Mid (2.1bn) 0 No activity — 15–50%
FR Orpea SA (ORP)
Healthcare Mid (2.1bn) 0 No activity — 0–15%
Industrials Mid (2.1bn) 0 No activity — 0–15%
Industrials Mid (2.1bn) 0 No activity — 0–15%
Financials Mid (2.1bn) 1–5 -$100K–$1M -0–15% 0–15%
Healthcare Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US Banner Corp (BANR)
Financials Mid (2.1bn) 0 No activity — 0–15%
BE Fagron NV (FAGR)
Healthcare Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Consumer Non-Cyclicals Mid (2.1bn) 0 No activity — 50%+
Consumer Cyclicals Mid (2.1bn) 0 No activity — 0–15%
Consumer Cyclicals Mid (2.1bn) 1–5 < $100K 0–15% 50%+
DE Vossloh AG (VOS)
Industrials Mid (2.1bn) 0 No activity — 50%+
AU Ansell Ltd (ANN)
Healthcare Mid (2.1bn) 0 No activity — 0–15%
Healthcare Mid (2.1bn) 1–5 $1M–$10M 0–15% 0–15%
Consumer Cyclicals Mid (2.1bn) -6–10 -$1M–$10M -0–15% 15–50%
IN IFCI Ltd (IFCI)
Financials Mid (2.1bn) 0 No activity — 50%+
Basic Materials Mid (2.1bn) 0 No activity — 0–15%
Industrials Mid (2.1bn) 0 No activity — 0–15%
Utilities Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
SE NCC AB (NCC-B)
Industrials Mid (2.1bn) 6–10 $100K–$1M 0–15% 0–15%
Healthcare Mid (2.1bn) 0 No activity — 0–15%
Consumer Cyclicals Mid (2.1bn) 0 No activity — 0–15%
Healthcare Mid (2.1bn) 0 No activity — 0–15%
- Mid (2.1bn) 0 No activity — 15–50%
Financials Mid (2.1bn) 0 No activity — 50%+
Financials Mid (2.1bn) 0 No activity — 0–15%
Financials Mid (2.1bn) 0 No activity — 0–15%
Industrials Mid (2.1bn) 0 No activity — —
US Zymeworks Inc (ZYME)
Healthcare Mid (2.1bn) 0 No activity — 0–15%
Consumer Cyclicals Mid (2.1bn) 0 No activity — 0–15%
Financials Mid (2.1bn) 1–5 $1M–$10M 0–15% 0–15%
Energy Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Consumer Non-Cyclicals Mid (2.1bn) 1–5 $1M–$10M 0–15% 15–50%
Industrials Mid (2.1bn) 0 No activity — 0–15%
Consumer Non-Cyclicals Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US NuVasive Inc (NUVA)
Healthcare Mid (2.1bn) 0 No activity — 0–15%
CH BB Biotech AG (BION)
Healthcare Mid (2.1bn) 0 No activity — 0–15%
Financials Mid (2.1bn) 0 No activity — 50%+
Consumer Cyclicals Mid (2.1bn) 0 No activity — 50%+
Financials Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US Immunome Inc (IMNM)
Healthcare Mid (2.1bn) 0 $100K–$1M 0–15% 0–15%
Healthcare Mid (2.1bn) 1–5 $10M–$100M 0–15% 15–50%
Healthcare Mid (2.1bn) 0 No activity — 0–15%
Financials Mid (2.1bn) 1–5 < $100K 0–15% 15–50%
Real Estate Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
Financials Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Consumer Cyclicals Mid (2.1bn) 0 No activity — 15–50%
Financials Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Technology Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Financials Mid (2.1bn) 0 No activity — 0–15%
Industrials Mid (2.1bn) 0 No activity — 0–15%
Consumer Cyclicals Mid (2.1bn) 0 No activity — 0–15%
US Interface Inc (TILE)
Consumer Cyclicals Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Technology Mid (2.1bn) 0 No activity — 15–50%
Financials Mid (2.1bn) 0 < $100K 0–15% 0–15%
GB Currys PLC (CURY)
Consumer Cyclicals Mid (2.1bn) 0 No activity — 0–15%
Consumer Cyclicals Mid (2.1bn) 1–5 $10M–$100M 0–15% 15–50%
Financials Mid (2.1bn) 0 No activity — 15–50%
Consumer Cyclicals Mid (2.1bn) 1–5 $1M–$10M 0–15% 50%+
Energy Mid (2.1bn) -1–5 -$10M–$100M -0–15% 0–15%
US Progyny Inc (PGNY)
Healthcare Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US OFG Bancorp (OFG)
Financials Mid (2.0bn) 0 No activity — 0–15%
Basic Materials Mid (2.0bn) 0 No activity — 0–15%
Healthcare Mid (2.0bn) 0 No activity — 0–15%